Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 8100 participants.
Also called NCT07507500
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 8,100 participants
- Sponsor
- Registry
-
NCT07507500
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Ireland, Latvia, Norway, Poland, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT07507500. Randomized; single masking; primary purpose treatment. Start 2026-09-02 (actual); primary completion 2029-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months
- Acronym
- STREAMLINE
- Condition
- Myocardial Infarction (MI)
- Intervention (Drug)
- Prasugrel
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Collaborator
- Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Record details
- Record id
cardio:ct-nct07507500- Content hash
252c6c6436b72cf629babc11bc7146a388f9af68208770d8e8d4bf1c5120359a